Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
FibroGen ( (FGEN) ) has issued an update.
FibroGen, Inc. has taken a strategic step to cut costs and safeguard its finances by terminating its lease early with landlord ARE-San Francisco No. 43 Owner, LLC for the property at 409 Illinois Street, San Francisco. The agreement, effective December 31, 2024, involves a $10 million settlement to cover past dues and a security deposit, freeing FibroGen from future rental and associated expenses. This move is aimed at improving the company’s cash flow and operational efficiency.
For a thorough assessment of FGEN stock, go to TipRanks’ Stock Analysis page.
